Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Inflammatory Bowel Diseases
|
November 9, 2025
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review
David T Rubin, Walter Reinisch, Neeraj Narula, et al.
Journal of Crohn'S & Colitis
|
July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme
Stefan Schreiber, David T Rubin, Siew C Ng, et al.
Journal of Crohn'S & Colitis
|
May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
Miguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
Manasi Agrawal, Erica J Brenner, Joyce Wing Yan Mak, et al.
Journal of Crohn'S & Colitis
|
April 13, 2024
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, et al.
Journal of Crohn'S & Colitis
|
February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Microorganisms
|
November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR Trial
Silvio Danese, Martina Goetsch, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
June 15, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials
Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Inflammatory Bowel Diseases
|
November 9, 2025
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review
David T Rubin, Walter Reinisch, Neeraj Narula, et al.
Journal of Crohn'S & Colitis
|
July 4, 2023
Major Adverse Cardiovascular Events by Baseline Cardiovascular Risk in Patients with Ulcerative Colitis Treated with Tofacitinib: Data from the OCTAVE Clinical Programme
Stefan Schreiber, David T Rubin, Siew C Ng, et al.
Journal of Crohn'S & Colitis
|
May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme
Miguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
BMJ Open Gastroenterology
|
January 8, 2025
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis
Séverine Vermeire, David T Rubin, Laurent Peyrin-Biroulet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2021
COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
Manasi Agrawal, Erica J Brenner, Joyce Wing Yan Mak, et al.
Journal of Crohn'S & Colitis
|
April 13, 2024
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme
Laurent Peyrin-Biroulet, Marla C Dubinsky, Bruce E Sands, et al.
Journal of Crohn'S & Colitis
|
February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential Solutions
Mathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Microorganisms
|
November 19, 2020
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 5, 2026
The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR Trial
Silvio Danese, Martina Goetsch, Laurent Peyrin-Biroulet, et al.
Journal of Crohn'S & Colitis
|
June 15, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials
Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, et al.
Page
of 5